℞ Prescription injectable Antibiotics
CS-TAZ 2.25
Piperacillin & Tazobactam for Injection I.P.
Powerful Combination for Severe Infections
2.25 gm Sterile Powder for Injection
- Broad Spectrum Antibacterial Activity
- Effective Against Multi-Drug Resistant Organisms
- Ideal for Severe Hospital Acquired Infections
- Suitable for Critical Care Settings
Specifications
| Composition | Piperacillin Sodium I.P. 2.0 gm; Tazobactam Sodium I.P. 0.25 gm |
|---|---|
| Strength | 2.25 gm |
| Dosage form | Sterile Powder for Injection |
| Pack size | 1 Vial (2.25 gm) with Sterile WFI |
| Route | For I.V. use only |
| Storage | Store below 25°C. Protect from moisture and light. |
Indications
- Complicated intra-abdominal infections
- Complicated urinary tract infections (cUTI)
- Hospital acquired pneumonia (HAP)
- Ventilator associated pneumonia (VAP)
- Skin and soft tissue infections (SSTI)
- Bone and joint infections
- Gynecological infections
- Sepsis and other mixed bacterial infections
- Empirical therapy in critically ill patients
Mechanism of action
Piperacillin is a broad-spectrum ureidopenicillin that inhibits bacterial cell wall synthesis. Tazobactam is a β-lactamase inhibitor that protects piperacillin from degradation by β-lactamase enzymes, thereby extending the spectrum of activity against β-lactamase producing organisms.
Dosage and administration
- To be administered by slow intravenous infusion.
- Reconstitute with provided sterile water for injection as per protocol.
- Dose and duration as directed by the Physician.
- Use only under medical supervision.
Safety information
- For I.V. use only.
- Use under strict medical supervision.
- Generally well tolerated; adverse effects may include gastrointestinal upset, rash or hypersensitivity reactions.
- Refer to full prescribing information for contraindications, precautions and adverse effects.
For use by registered medical practitioners, hospitals and laboratories only. Refer to the full prescribing information before use.
